Results 61 to 70 of about 1,278,840 (295)

FaCE: a tool for Three Body Faddeev calculations with core excitation

open access: yes, 2004
FaCE is a self contained programme, with namelist input, that solves the three body Faddeev equations. It enables the inclusion of excitation of one of the three bodies, whilst the other two remain inert.
Al-Khalili   +22 more
core   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Small surfactant-like peptides can drive soluble proteins into active aggregates

open access: yesMicrobial Cell Factories, 2012
Background Inactive protein inclusion bodies occur commonly in Escherichia coli (E. coli) cells expressing heterologous proteins. Previously several independent groups have found that active protein aggregates or pseudo inclusion bodies can be induced by
Zhou Bihong   +4 more
doaj   +1 more source

Studies on the Structure and Properties of Membrane Phospholipase A1 Inclusion Bodies Formed at Low Growth Temperatures Using GFP Fusion Strategy

open access: yesMolecules, 2021
The effect of cultivation temperatures (37, 26, and 18 °C) on the conformational quality of Yersinia pseudotuberculosis phospholipase A1 (PldA) in inclusion bodies (IBs) was studied using green fluorescent protein (GFP) as a folding reporter.
Svetlana I. Bakholdina   +9 more
doaj   +1 more source

From glycogen metabolism to Lafora disease [PDF]

open access: yes, 2016
Glycogen synthesis is normally absent in neurons. However, inclusion bodies resembling abnormal glycogen accumulate in several neurological diseases, particularly in progressive myoclonus epilepsy or Lafora disease.
Guinovart, Joan
core  

Faddeev calculations of break-up reactions with realistic experimental constraints

open access: yes, 2004
We present a method to integrate predictions from a theoretical model of a reaction with three bodies in the final state over the region of phase space covered by a given experiment. The method takes into account the true experimental acceptance, as well
Engblom, P. Thorngren   +8 more
core   +1 more source

The stability and activity of human neuroserpin are modulated by a salt bridge that stabilises the reactive centre loop [PDF]

open access: yes, 2015
Neuroserpin (NS) is an inhibitory protein belonging to the serpin family and involved in several pathologies, including the dementia Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB), a genetic neurodegenerative disease caused by ...
Caccia, Sonia   +7 more
core   +1 more source

Schaumann bodies: The basophilic inclusion body

open access: yesJournal of Oral and Maxillofacial Pathology, 2023
Schaumann bodies are the inclusion bodies usually seen in sarcoidosis, but can also be found in other conditions like tuberculosis, chronic beryllium diseases and Crohn’s diseases. Histopathologically, these bodies appear as round to oval shell-like basophilic calcifications usually considered to be as a residuum of lysosomal organelles activity.
Jain, Ankush P.   +3 more
openaire   +2 more sources

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Must we live with inclusion bodies? [PDF]

open access: yes, 2017
High expression levels of recombinant proteins do not necessarily mean that the protein must be in inclusion bodies (IBs). This talk will describe some of the more successful solutions to the problem of expressing proteins in an active form in E ...
Schein, Catherine H.
core  

Home - About - Disclaimer - Privacy